Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2007

Conditions
Healthy
Interventions
DRUG

BI 44847 solution, low dose

DRUG

BI 44847 suspension, high dose

DRUG

BI 44847 tablet, low dose

DRUG

BI 44847 tablet, high dose

OTHER

high fat breakfast

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY